CircadifyCircadify
Engineering9 min read

The Hidden Costs of Building a Vitals SDK In-House

Details the often-overlooked expenses of an in-house build, including long-term maintenance, clinical validation, and specialized engineering talent.

telehealthvitals.com Research Team·
The Hidden Costs of Building a Vitals SDK In-House

Engineering leadership at telehealth platforms face a constant barrage of build-versus-buy decisions. When a clinical team requests contactless vital sign monitoring, the initial engineering instinct is often to assign a small team to explore open-source computer vision libraries. Remote photoplethysmography relies on standard optical principles: tracking microscopic changes in light absorption associated with the cardiac cycle. However, transitioning from a proof-of-concept algorithm to a regulatory-ready rPPG SDK telehealth integration requires an entirely different operational model. This transition introduces a steep exponential curve in both capital expenditure and operational maintenance, transforming a standard software feature into a rigorous clinical device project. What begins as a sprint to extract a pulse signal rapidly becomes a multi-year regulatory marathon.

"The median regulatory costs for clearance of a medical device, including Software as a Medical Device, reach approximately 3.1 million dollars. Engineering teams frequently report that bringing their first clinical software project to market costs up to five times more than initial estimates."

  • BrightInsight Research, 2023

The Architecture and the rPPG SDK Telehealth Decision

When a platform decides to build an rPPG SDK telehealth integration internally, the initial prototype is rarely the hurdle. A senior computer vision engineer can likely extract a raw blood volume pulse signal from webcam video within a few sprints using basic facial tracking and color space transformations. The hidden costs emerge immediately after this proof of concept. Building an in-house remote photoplethysmography pipeline requires accounting for extreme environmental variability. Telehealth patients do not sit in perfectly illuminated studios; they take video visits in dimly lit bedrooms, bright sunrooms, and moving vehicles.

When engineers first access the pixel data from a standard web camera, they are capturing a mix of ambient light, monitor glow, and the user's pulse. Separating the pulse requires independent component analysis or deep learning architectures capable of isolating the specific frequency of human blood flow. If a telehealth platform attempts to build this in-house, they must construct a data pipeline capable of handling gigabytes of uncompressed video per patient just to train the initial models. Storing, annotating, and processing this video data in a HIPAA-compliant environment incurs significant cloud computing costs.

Moreover, the engineering team must solve the liveness problem. A clinical-grade system must differentiate between a live human face, a high-resolution photograph, or a pre-recorded video to prevent spoofing and ensure patient safety.

Furthermore, device fragmentation adds a massive layer of complexity. Telehealth platforms operate across thousands of combinations of hardware, operating systems, and browsers. An algorithm tuned for a high-end smartphone camera processing 60 frames per second will fail on a five-year-old laptop struggling to output 15 frames per second over a degraded connection.

Financial breakdown: the cost of clinical validation

The most severe miscalculation in these projects occurs around regulatory compliance and clinical validation. Extracting vital signs for clinical use transitions the software into the category of Software as a Medical Device.

Achieving compliance is not a one-time paperwork exercise; it is an organizational shift. The organization must implement a Quality Management System compliant with standard regulations, requiring dedicated quality assurance personnel, rigorous document control, and specific software development lifecycles that slow down traditional agile methodologies.

The clinical trials required to prove efficacy are expensive. Industry benchmarks from Complizen (2023) indicate that a standard regulatory submission for a Class II medical device can cost between $75,000 and $200,000 in direct preparation and submission fees alone. However, the clinical validation trials required to support that submission range from $500,000 to over $2,500,000. These trials must statistically prove that the algorithm works across different ages, body mass indices, and specifically, across the entire Fitzpatrick scale of skin tones. Failing to adequately represent darker skin tones in training and validation data leads to biased algorithms that fail in clinical practice, a risk that regulatory bodies heavily scrutinize.

Beyond the initial trials, regulatory bodies are increasingly enforcing post-market surveillance requirements for software medical devices. This means the engineering team must continuously monitor the algorithm's performance in the real world, investigate any reported anomalies, and submit regular safety updates. Each time the underlying mobile operating systems update their camera APIs, the in-house team must perform regression testing to prove the vital sign measurements remain accurate. If a major platform like iOS or Android changes how it handles video compression or background processing, an unmaintained algorithm can silently fail, reporting inaccurate heart rates that could misguide a clinician.

| Factor | In-House rPPG Development | Commercial Video Vitals SDK | |---|---|---| | Initial Capital Expenditure | $500,000 to $3,000,000+ | Low (Subscription or Usage-based) | | Time to Market | 18 to 36 months | 2 to 4 weeks | | Clinical Validation | Internal burden (Trials required) | Provided by the vendor | | Regulatory Overhead | Heavy (QMS setup required) | Vendor manages compliance | | Maintenance and Updates | Continuous internal engineering tax | Managed externally |

Hidden operational burdens

The expenses do not stop at launch. Maintaining an in-house algorithm requires a dedicated team and continuous capital investment.

  • Specialized talent acquisition: Hiring researchers in optical physics and computer vision is expensive and highly competitive.
  • Infrastructure for clinical trials: Sourcing ground-truth data requires ongoing partnerships with clinical research organizations.
  • Quality Management System overhead: Maintaining compliance means every minor software update must go through rigorous, documented verification and validation processes.
  • Device matrix testing: Handling variable framerates and sensor artifacts across differing operating systems and WebRTC streams requires a massive device lab.
  • Algorithm retraining: As new cameras and compression standards emerge, the core models require continuous retraining and redeployment.

Industry applications and architectural demands

Synchronous video visits

The most common application for contactless vitals is during live video consultations. In this environment, the algorithm must process video frames locally on the patient's device to avoid transmitting heavy, uncompressed video to a server. Building edge-computing models that run efficiently on older mobile devices without draining the battery or overheating the processor requires highly specialized optimization engineering.

Asynchronous clinical intake

Many telehealth platforms are moving toward asynchronous care models. Here, patients record short video clips during the intake process. The system must analyze these clips, extract vital signs, and structure the data into interoperable formats for the electronic health record. Building the pipeline to normalize this data and integrate it with existing clinical workflows adds months to the development timeline.

Continuous patient monitoring

While episodic checks are the starting point, the industry is moving toward longer-term monitoring during virtual observation or hospital-at-home programs. This requires the software to run continuously, managing varying lighting conditions as the sun goes down or room lights change, while maintaining a reliable signal-to-noise ratio.

Current research and evidence

The academic literature surrounding optical vital sign measurement highlights the immense difficulty of moving from a controlled laboratory setting to real-world clinical applications. Research by Daniel McDuff at Microsoft Research (2023) extensively documents these hurdles. In his comprehensive survey of camera measurement for physiological vital signs published in ACM Computing Surveys, McDuff details the complex physics involved in separating the subtle blood volume pulse signal from massive environmental noise.

McDuff's research points out that while alternative color channels or multi-band cameras can improve signal recovery, standard consumer hardware compresses video in ways that actively destroy the precise pixel variations remote photoplethysmography relies on. Furthermore, academic studies frequently note the historical lack of diversity in computer vision training data. A robust clinical algorithm requires validation against specialized ground-truth hardware, such as continuous non-invasive arterial pressure monitors, across thousands of diverse participants. Replicating the depth of this peer-reviewed research within a corporate engineering department requires a massive diversion of resources away from the telehealth platform's core product features.

The future of contactless vitals

The trajectory of remote physiological monitoring suggests that basic vital signs like heart rate and respiration will soon become standard features in virtual care. The differentiation will lie in the ability to measure more complex cardiovascular metrics, such as blood pressure trends and metabolic indicators, purely through software. As machine learning models become more sophisticated, the required training datasets will grow exponentially larger and more expensive to acquire. Telehealth platforms that attempt to build these capabilities internally will find themselves perpetually years behind commercial providers who focus entirely on sensor technology. The future belongs to platforms that assemble the best modular technologies, rather than those that attempt to invent every component from scratch.

Frequently asked questions

What is the difference between an open-source rPPG library and a clinical SDK?

Open-source libraries typically provide basic signal extraction algorithms that work in controlled lighting with minimal movement. A clinical SDK includes proprietary noise cancellation, edge-case handling for variable skin tones and lighting, device-specific optimizations, and rigorous clinical validation documentation required for regulatory compliance.

How much does a regulatory clearance cost for an in-house vital signs feature?

According to industry benchmarks, the direct costs for preparing and submitting a regulatory file for a Class II medical device range from $75,000 to $200,000. However, the mandatory clinical trials required to prove the software's accuracy and safety can add $500,000 to several million dollars to the total project cost.

Why is cross-demographic validation so expensive for camera-based vitals?

Camera-based algorithms rely on light reflection, which interacts differently with varying melanin levels in the skin. Proving that an algorithm is unbiased requires recruiting large, specific patient cohorts across the entire Fitzpatrick scale, conducting supervised data collection with reference medical devices, and analyzing the results. This is a logistically complex and costly process.

Does building an rPPG feature internally require a Quality Management System?

Yes. If the software is intended to measure vital signs for clinical decision-making, it generally qualifies as Software as a Medical Device. Regulatory bodies require the developing organization to implement and maintain a strict Quality Management System to ensure ongoing safety and efficacy.

The decision to integrate vital signs into a virtual care platform is a significant clinical advancement, but it does not require a massive internal engineering diversion. By evaluating the actual costs of data collection, regulatory compliance, and continuous maintenance, most engineering leaders realize that specialized vendor solutions offer a far more sustainable path. Circadify is actively addressing this space with developer-focused solutions designed for rapid integration. To explore the documentation and evaluate a deployment strategy, visit circadify.com/custom-builds.

telehealth architecturesoftware developmentrPPG integrationbuild vs buy
Request a Platform Demo